Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1

References

• Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology [Journal Article; Multicenter Study; Research Support, Non-U.S. Gov’t]. 2006 March 01;43(3):515–524.
   PubMed Web of Science ®Google Scholar
• Burrel M, Llovet JM, Ayuso C, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology [Journal Article; Research Support, Non-U.S. Gov’t]. 2003 Oct 01;38(4):1034–1042.
   PubMed Web of Science ®Google Scholar
• Han ZG. Functional genomic studies: insights into the pathogenesis of liver cancer. Annu Rev Genomics Hum Genet [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2012 Jan 20;13:171–205.
   PubMed Web of Science ®Google Scholar
• Park JM, Kim TH, Bae JS, et al. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver. Biochem Biophys Res Commun [Journal Article; Research Support, Non-U.S. Gov’t]. 2010 Dec 17;403(3–4):329–334.
   PubMed Web of Science ®Google Scholar
• Braconi C, Kogure T, Valeri N, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011 Jan 01;30(47):4750–4756.
   PubMed Web of Science ®Google Scholar
• Fornari F, Milazzo M, Chieco P, et al. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res [Journal Article]. 2010 June 15;70(12):5184–5193.
   PubMed Web of Science ®Google Scholar
• Xiong X, Tao R, DePinho RA, et al. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis. Plos One [Journal Article; Research Support, N.I.H., Extramural]. 2013 Jan 20;8(8):e74340.
   PubMed Web of Science ®Google Scholar
• Guo X, Gao L, Wang Y, et al. Advances in long noncoding RNAs: identification, structure prediction and function annotation. Brief Funct Genomics [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2016 Jan 01;15(1):38–46.
   PubMed Web of Science ®Google Scholar
• Hsieh PF, Yu CC, Chu PM, et al. Long non-coding RNA MEG3 in cellular stemness. Int J Mol Sci [Journal Article; Review]. 2021 May 19;22:10.
   Google Scholar
• Al-Rugeebah A, Alanazi M, Parine NR. MEG3: an oncogenic long non-coding RNA in different cancers. Pathol Oncol Res [Journal Article; Review]. 2019 July 01;25(3):859–874.
   PubMed Web of Science ®Google Scholar
• Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci [Journal Article]. 2017 Oct 01;21(17):3850–3856.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu J, Lv Y, et al. LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies. Am J Transl Res [Journal Article]. 2019 Jan 20;11(7):4089–4099.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen J, Jiang S, et al. N-Acetyltransferase 10 enhances doxorubicin resistance in human hepatocellular carcinoma cell lines by promoting the epithelial-to-mesenchymal transition. Oxid Med Cell Longev [Journal Article]. 2019 Jan 20;2019:7561879.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ren H, Dai B, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res [Journal Article]. 2018 Dec 27;37(1):324.
   PubMed Web of Science ®Google Scholar
• Wang J, He H, Jiang Q, et al. CBX6 promotes HCC metastasis via transcription factors Snail/Zeb1-mediated EMT mechanism. Onco Targets Ther [Journal Article]. 2020 Jan 20;13:12489–12500.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Cheng S, Cao L, et al. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway. Biosci Rep [Journal Article]. 2020 March 27;40:3.
   Web of Science ®Google Scholar
• Guo D, Zhang D, Ren M, et al. THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway. FASEB J [Journal Article; Research Support, Non-U.S. Gov’t]. 2020 Aug 01;34(8):10668–10681.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhou JK, Peng Y, et al. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2020 April 15;19(1):77.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2013 Oct 10;339(2):159–166.
   PubMed Web of Science ®Google Scholar
• Zhuo H, Tang J, Lin Z, et al. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma. Mol Carcinog [Journal Article; Research Support, Non-U.S. Gov’t]. 2016 Feb 01;55(2):209–219.
   PubMed Web of Science ®Google Scholar
• Xue R, Dong L, Zhang S, et al. Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. Rapid Commun Mass SP. 2008 Jan 01;22(8):1181–1186.
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet [Journal Article; Review]. 2015 Oct 01;52(10):710–718.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen JY, Zhong Y, et al. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11. Braz J Med Biol Res [Journal Article]. 2019 Jan 20;52(10):e8631.
   PubMed Web of Science ®Google Scholar
• Li X, Cheng T, He Y, et al. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway. Life Sci [Journal Article]. 2019 Sep 01;232:116602.
   PubMed Web of Science ®Google Scholar
• He JH, Han ZP, Liu JM, et al. Overexpression of long non-coding RNA MEG3 inhibits proliferation of hepatocellular carcinoma Huh7 cells via negative modulation of miRNA-664. J Cell Biochem [Journal Article; Research Support, Non-U.S. Gov’t]. 2017 Nov 01;118(11):3713–3721.
   PubMed Web of Science ®Google Scholar
• Song Z, Guo Q, Wang H, et al. miR-5193, regulated by FUT1, suppresses proliferation and migration of ovarian cancer cells by targeting TRIM11. Pathol Res Pract [Journal Article]. 2020 Nov 01;216(11):153148.
   PubMed Web of Science ®Google Scholar
• Yang J, Li T, Gao C, et al. FOXO1 3ʹUTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. Febs Lett [Journal Article; Research Support, Non-U.S. Gov’t]. 2014 Aug 25;588(17):3218–3224.
   PubMed Web of Science ®Google Scholar
• Yu W, Qiao Y, Tang X, et al. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal [Journal Article; Research Support, Non-U.S. Gov’t]. 2014 Dec 01;26(12):2961–2968.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yang J, Liao W, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol [Journal Article; Research Support, Non-U.S. Gov’t]. 2010 July 01;12(7):665–675.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang G, Li P, et al. miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma. Tumour Biol [Journal Article]. 2016 April 01;37(4):5193–5202.
   PubMedGoogle Scholar
• He XX, Chang Y, Meng FY, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene [Journal Article; Research Support, Non-U.S. Gov’t]. 2012 July 12;31(28):3357–3369.
   PubMed Web of Science ®Google Scholar
• Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012 Jan 01;113(6):1868–1874.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang Q, Wang F. Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma. Tumour Biol [Journal Article; Retracted Publication]. 2014 July 01;35(7):7195–7200.
   PubMedGoogle Scholar
• Walters ZS, Villarejo-Balcells B, Olmos D, et al. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Oncogene [Journal Article; Research Support, Non-U.S. Gov’t]. 2014 Feb 27;33(9):1148–1157.
   PubMed Web of Science ®Google Scholar
• Huang J, Jiao J, Xu W, et al. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Mol Med Rep [Journal Article]. 2015 Nov 01;12(5):7102–7108.
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Yamauchi T, Ito Y, et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem [Journal Article]. 2004 July 16;279(29):30817–30822.
   PubMed Web of Science ®Google Scholar
• Jiang J, Huang Z, Chen X, et al. Trifluoperazine activates FOXO1-related signals to inhibit tumor growth in hepatocellular carcinoma. DNA Cell Biol [Journal Article]. 2017 Oct 01;36(10):813–821.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang X, Zhou X, et al. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma. Biochem Biophys Res Commun [Journal Article; Research Support, Non-U.S. Gov’t]. 2020 June 11;526(4):889–897.
   PubMed Web of Science ®Google Scholar